Ralph Niven
Chief Development Officer, Jade Biosciences, Inc.
Companies
- Jade Biosciences, Inc.Chief Development Officer Jun 29, 2021 to Feb 7, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jade Biosciences, Inc. JBIO1,609 shares2$21.8K at $13.56Feb 5, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 5, 2024Sold 4,600 shares at $17.45 of Jade Biosciences, Inc.2
- Feb 5, 2024Exercised options 3,200 shares at $2.14 of Jade Biosciences, Inc.2
- Feb 5, 2024Exercised options 1,400 shares at $1.74 of Jade Biosciences, Inc.2
- Jan 5, 2024Sold 2,474 shares at $19.57 of Jade Biosciences, Inc.3
- Jan 5, 2024Sold 2,126 shares at $18.67 of Jade Biosciences, Inc.3
- Jan 5, 2024Exercised options 3,200 shares at $2.14 of Jade Biosciences, Inc.3
- Jan 5, 2024Exercised options 1,400 shares at $1.74 of Jade Biosciences, Inc.3
- Dec 5, 2023Sold 4,600 shares at $16.30 of Jade Biosciences, Inc.4
- Dec 5, 2023Exercised options 3,200 shares at $2.14 of Jade Biosciences, Inc.4
- Dec 5, 2023Exercised options 1,400 shares at $1.74 of Jade Biosciences, Inc.4
- Nov 22, 2023Sold 13,800 shares at $15.00 of Jade Biosciences, Inc.5
- Nov 22, 2023Exercised options 9,600 shares at $2.14 of Jade Biosciences, Inc.5
- Nov 22, 2023Exercised options 4,200 shares at $1.74 of Jade Biosciences, Inc.5
- Jul 5, 2023Sold 219 shares at $17.87 of Jade Biosciences, Inc.6
- Jul 5, 2023Sold 2,031 shares at $17.23 of Jade Biosciences, Inc.6
- Jul 5, 2023Exercised options 1,600 shares at $2.14 of Jade Biosciences, Inc.6
- Jul 5, 2023Exercised options 650 shares at $1.74 of Jade Biosciences, Inc.6
- Jun 5, 2023Sold 2,250 shares at $16.26 of Jade Biosciences, Inc.7
- Jun 5, 2023Exercised options 1,600 shares at $2.14 of Jade Biosciences, Inc.7
- Jun 5, 2023Exercised options 650 shares at $1.74 of Jade Biosciences, Inc.7
- May 5, 2023Sold 205 shares at $21.63 of Jade Biosciences, Inc.8
- May 5, 2023Sold 2,045 shares at $20.79 of Jade Biosciences, Inc.8
- May 5, 2023Exercised options 1,600 shares at $2.14 of Jade Biosciences, Inc.8
- May 5, 2023Exercised options 650 shares at $1.74 of Jade Biosciences, Inc.8
- Apr 5, 2023Sold 535 shares at $19.11 of Jade Biosciences, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jan 8, 2024
- 4SEC EDGARForm 4 filed Dec 7, 2023
- 5SEC EDGARForm 4 filed Nov 27, 2023
- 6SEC EDGARForm 4 filed Jul 7, 2023
- 7SEC EDGARForm 4 filed Jun 7, 2023
- 8SEC EDGARForm 4 filed May 9, 2023
- 9SEC EDGARForm 4 filed Apr 7, 2023